TABLE 1 NUMBER OF GENETIC TESTING LABORATORIES IN EU
TABLE 2 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 3 GLOBAL CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 4 GLOBAL CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 5 GLOBAL GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION))
TABLE 6 GLOBAL METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 7 GLOBAL LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 8 GLOBAL URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 9 GLOBAL CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 10 GLOBAL CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION))
TABLE 11 GLOBAL HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 12 GLOBAL HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)))
TABLE 13 GLOBAL COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 14 GLOBAL MOLECULAR DIAGNOSTIC IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 15 GLOBAL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 16 GLOBAL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 17 GLOBAL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 18 GLOBAL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 19 GLOBAL MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 20 GLOBAL MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION))
TABLE 21 GLOBAL OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 22 GLOBAL OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 23 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 GLOBAL CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 GLOBAL CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 26 GLOBAL ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 27 GLOBAL ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 GLOBAL ACCESSORIES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 30 GLOBAL BLOOD IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 31 GLOBAL URINE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 32 GLOBAL TISSUE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 GLOBAL CEREBROSPINAL FLUID (CSF) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 34 GLOBAL OTHERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 35 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 36 GLOBAL INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 37 GLOBAL INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 38 GLOBAL GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 39 GLOBAL GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 40 GLOBAL ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 41 GLOBAL ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 42 GLOBAL AUTOIMMUNE DISEASE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 43 GLOBAL UROLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 44 GLOBAL GYNECOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 45 GLOBAL OTHERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 47 GLOBAL MALE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 GLOBAL FEMALE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 50 GLOBAL GERIATRICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 51 GLOBAL ADULT IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 GLOBAL PEDIATRICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 54 GLOBAL HOSPITAL-BASED LAB IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 55 GLOBAL STAND- ALONE LABS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 GLOBAL DIAGNOSTIC CHAINS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 GLOBAL ACADEMIC INSTITUTES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 GLOBAL CLINICAL RESEARCH ORGANISATION IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 59 GLOBAL SPECIALTY DIAGNOSTIC IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 60 GLOBAL OTHERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 61 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 62 GLOBAL DIRECT TENDER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 63 GLOBAL RETAIL SALES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 64 GLOBAL DIRECT TENDER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 65 GLOBAL OTHERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 66 GLOBAL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 67 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 68 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 69 NORTH AMERICA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 70 NORTH AMERICA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 71 NORTH AMERICA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 72 NORTH AMERICA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 73 NORTH AMERICA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 74 NORTH AMERICA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 75 NORTH AMERICA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 76 NORTH AMERICA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 77 NORTH AMERICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 78 NORTH AMERICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 79 NORTH AMERICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 80 NORTH AMERICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 81 NORTH AMERICA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 82 NORTH AMERICA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 83 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 84 NORTH AMERICA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 85 NORTH AMERICA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 86 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 87 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 88 NORTH AMERICA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 89 NORTH AMERICA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 90 NORTH AMERICA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 91 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 92 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 93 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 94 NORTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 95 U.S. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 96 U.S. CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 97 U.S. GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 98 U.S. METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 99 U.S. LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 100 U.S. URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 101 U.S. CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 102 U.S. HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 103 U.S. COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 104 U.S. MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 105 U.S. MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 106 U.S. MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 107 U.S. MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 108 U.S. MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 109 U.S. OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 110 U.S. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 111 U.S. CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 112 U.S. ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 113 U.S. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 114 U.S. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 115 U.S. INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 116 U.S. GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 117 U.S. ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 118 U.S. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 119 U.S. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 120 U.S. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 121 U.S. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 122 CANADA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 123 CANADA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 124 CANADA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 125 CANADA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 126 CANADA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 127 CANADA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 128 CANADA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 129 CANADA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 130 CANADA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 131 CANADA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 132 CANADA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 133 CANADA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 134 CANADA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 135 CANADA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 136 CANADA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 137 CANADA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 CANADA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 CANADA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 140 CANADA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 141 CANADA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 142 CANADA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 143 CANADA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 144 CANADA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 145 CANADA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 146 CANADA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 147 CANADA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 148 CANADA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 149 MEXICO LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 150 MEXICO CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 151 MEXICO GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 152 MEXICO METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 153 MEXICO LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 154 MEXICO URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 155 MEXICO CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 156 MEXICO HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 157 MEXICO COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 158 MEXICO MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 159 MEXICO MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 160 MEXICO MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 161 MEXICO MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 162 MEXICO MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 163 MEXICO OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 164 MEXICO LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 165 MEXICO CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 166 MEXICO ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 167 MEXICO LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 168 MEXICO LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 169 MEXICO INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 170 MEXICO GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 171 MEXICO ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 172 MEXICO LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 173 MEXICO LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 174 MEXICO LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 175 MEXICO LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 176 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 177 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 178 EUROPE CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 179 EUROPE GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 180 EUROPE METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 181 EUROPE LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 182 EUROPE URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 183 EUROPE CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 184 EUROPE HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 185 EUROPE COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 186 EUROPE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 187 EUROPE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 188 EUROPE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 189 EUROPE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 190 EUROPE MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 191 EUROPE OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 192 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 193 EUROPE CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 194 EUROPE ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 196 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 197 EUROPE INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 198 EUROPE GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 199 EUROPE ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 200 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 201 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 202 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 203 EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 204 GERMANY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 205 GERMANY CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 206 GERMANY GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 207 GERMANY METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 208 GERMANY LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 209 GERMANY URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 210 GERMANY CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 211 GERMANY HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 212 GERMANY COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 213 GERMANY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 214 GERMANY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 215 GERMANY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 216 GERMANY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 217 GERMANY MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 218 GERMANY OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 219 GERMANY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 220 GERMANY CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 221 GERMANY ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 222 GERMANY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 223 GERMANY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 224 GERMANY INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 225 GERMANY GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 226 GERMANY ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 227 GERMANY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 228 GERMANY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 229 GERMANY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 230 GERMANY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 231 U.K. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 232 U.K. CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 233 U.K. GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 234 U.K. METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 235 U.K. LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 236 U.K. URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 237 U.K. CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 238 U.K. HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 239 U.K. COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 240 U.K. MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 241 U.K. MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 242 U.K. MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 243 U.K. MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 244 U.K. MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 245 U.K. OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 246 U.K. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 247 U.K. CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 248 U.K. ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 249 U.K. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 250 U.K. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 251 U.K. INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 252 U.K. GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 253 U.K. ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 254 U.K. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 255 U.K. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 256 U.K. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 257 U.K. LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 258 FRANCE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 259 FRANCE CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 260 FRANCE GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 261 FRANCE METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 262 FRANCE LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 263 FRANCE URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 264 FRANCE CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 265 FRANCE HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 266 FRANCE COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 267 FRANCE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 268 FRANCE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 269 FRANCE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 270 FRANCE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 271 FRANCE MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 272 FRANCE OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 273 FRANCE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 274 FRANCE CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 275 FRANCE ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 276 FRANCE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 277 FRANCE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 278 FRANCE INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 279 FRANCE GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 280 FRANCE ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 281 FRANCE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 282 FRANCE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 283 FRANCE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 284 FRANCE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 285 ITALY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 286 ITALY CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 287 ITALY GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 288 ITALY METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 289 ITALY LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 290 ITALY URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 291 ITALY CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 292 ITALY HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 293 ITALY COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 294 ITALY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 295 ITALY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 296 ITALY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 297 ITALY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 298 ITALY MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 299 ITALY OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 300 ITALY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 301 ITALY CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 302 ITALY ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 303 ITALY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 304 ITALY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 305 ITALY INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 306 ITALY GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 307 ITALY ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 308 ITALY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 309 ITALY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 310 ITALY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 311 ITALY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 312 RUSSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 313 RUSSIA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 314 RUSSIA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 315 RUSSIA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 316 RUSSIA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 317 RUSSIA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 318 RUSSIA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 319 RUSSIA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 320 RUSSIA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 321 RUSSIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 322 RUSSIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 323 RUSSIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 324 RUSSIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 325 RUSSIA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 326 RUSSIA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 327 RUSSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 328 RUSSIA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 329 RUSSIA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 RUSSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 331 RUSSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 332 RUSSIA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 333 RUSSIA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 334 RUSSIA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 335 RUSSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 336 RUSSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 337 RUSSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 338 RUSSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 339 SPAIN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 340 SPAIN CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 341 SPAIN GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 342 SPAIN METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 343 SPAIN LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 344 SPAIN URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 345 SPAIN CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 346 SPAIN HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 347 SPAIN COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 348 SPAIN MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 349 SPAIN MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 350 SPAIN MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 351 SPAIN MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 352 SPAIN MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 353 SPAIN OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 354 SPAIN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 355 SPAIN CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 356 SPAIN ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 357 SPAIN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 358 SPAIN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 359 SPAIN INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 360 SPAIN GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 361 SPAIN ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 362 SPAIN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 363 SPAIN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 364 SPAIN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 365 SPAIN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 366 NETHERLANDS LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 367 NETHERLANDS CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 368 NETHERLANDS GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 369 NETHERLANDS METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 370 NETHERLANDS LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 371 NETHERLANDS URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 372 NETHERLANDS CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 373 NETHERLANDS HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 374 NETHERLANDS COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 375 NETHERLANDS MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 376 NETHERLANDS MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 377 NETHERLANDS MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 378 NETHERLANDS MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 379 NETHERLANDS MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 380 NETHERLANDS OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 381 NETHERLANDS LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 382 NETHERLANDS CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 383 NETHERLANDS ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 384 NETHERLANDS LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 385 NETHERLANDS LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 386 NETHERLANDS INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 387 NETHERLANDS GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 388 NETHERLANDS ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 389 NETHERLANDS LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 390 NETHERLANDS LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 391 NETHERLANDS LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 392 NETHERLANDS LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 393 SWITZERLAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 394 SWITZERLAND CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 395 SWITZERLAND GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 396 SWITZERLAND METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 397 SWITZERLAND LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 398 SWITZERLAND URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 399 SWITZERLAND CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 400 SWITZERLAND HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 401 SWITZERLAND COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 402 SWITZERLAND MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 403 SWITZERLAND MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 404 SWITZERLAND MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 405 SWITZERLAND MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 406 SWITZERLAND MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 407 SWITZERLAND OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 408 SWITZERLAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 409 SWITZERLAND CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 410 SWITZERLAND ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 411 SWITZERLAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 412 SWITZERLAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 413 SWITZERLAND INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 414 SWITZERLAND GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 415 SWITZERLAND ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 416 SWITZERLAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 417 SWITZERLAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 418 SWITZERLAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 419 SWITZERLAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 420 BELGIUM LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 421 BELGIUM CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 422 BELGIUM GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 423 BELGIUM METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 424 BELGIUM LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 425 BELGIUM URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 426 BELGIUM CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 427 BELGIUM HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 428 BELGIUM COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 429 BELGIUM MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 430 BELGIUM MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 431 BELGIUM MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 432 BELGIUM MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 433 BELGIUM MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 434 BELGIUM OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 435 BELGIUM LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 436 BELGIUM CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 437 BELGIUM ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 438 BELGIUM LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 439 BELGIUM LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 440 BELGIUM INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 441 BELGIUM GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 442 BELGIUM ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 443 BELGIUM LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 444 BELGIUM LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 445 BELGIUM LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 446 BELGIUM LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 447 TURKEY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 448 TURKEY CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 449 TURKEY GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 450 TURKEY METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 451 TURKEY LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 452 TURKEY URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 453 TURKEY CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 454 TURKEY HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 455 TURKEY COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 456 TURKEY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 457 TURKEY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 458 TURKEY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 459 TURKEY MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 460 TURKEY MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 461 TURKEY OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 462 TURKEY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 463 TURKEY CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 464 TURKEY ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 465 TURKEY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 466 TURKEY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 467 TURKEY INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 468 TURKEY GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 469 TURKEY ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 470 TURKEY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 471 TURKEY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 472 TURKEY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 473 TURKEY LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 474 REST OF EUROPE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 475 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 476 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 477 ASIA-PACIFIC CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 478 ASIA-PACIFIC GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 479 ASIA-PACIFIC METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 480 ASIA-PACIFIC LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 481 ASIA-PACIFIC URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 482 ASIA-PACIFIC CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 483 ASIA-PACIFIC HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 484 ASIA-PACIFIC COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 485 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 486 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 487 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 488 ASIA-PACIFIC MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 489 ASIA-PACIFIC MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 490 ASIA-PACIFIC OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 491 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 492 ASIA-PACIFIC CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 493 ASIA-PACIFIC ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 494 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 495 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 496 ASIA-PACIFIC INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 497 ASIA-PACIFIC GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 498 ASIA-PACIFIC ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 499 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 500 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 501 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 502 ASIA-PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 503 CHINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 504 CHINA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 505 CHINA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 506 CHINA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 507 CHINA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 508 CHINA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 509 CHINA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 510 CHINA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 511 CHINA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 512 CHINA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 513 CHINA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 514 CHINA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 515 CHINA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 516 CHINA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 517 CHINA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 518 CHINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 519 CHINA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 520 CHINA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 521 CHINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 522 CHINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 523 CHINA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 524 CHINA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 525 CHINA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 526 CHINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 527 CHINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 528 CHINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 529 CHINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 530 JAPAN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 531 JAPAN CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 532 JAPAN GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 533 JAPAN METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 534 JAPAN LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 535 JAPAN URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 536 JAPAN CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 537 JAPAN HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 538 JAPAN COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 539 JAPAN MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 540 JAPAN MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 541 JAPAN MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 542 JAPAN MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 543 JAPAN MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 544 JAPAN OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 545 JAPAN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 546 JAPAN CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 547 JAPAN ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 548 JAPAN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 549 JAPAN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 550 JAPAN INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 551 JAPAN GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 552 JAPAN ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 553 JAPAN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 554 JAPAN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 555 JAPAN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 556 JAPAN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 557 INDIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 558 INDIA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 559 INDIA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 560 INDIA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 561 INDIA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 562 INDIA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 563 INDIA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 564 INDIA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 565 INDIA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 566 INDIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 567 INDIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 568 INDIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 569 INDIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 570 INDIA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 571 INDIA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 572 INDIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 573 INDIA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 574 INDIA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 575 INDIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 576 INDIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 577 INDIA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 578 INDIA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 579 INDIA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 580 INDIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 581 INDIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 582 INDIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 583 INDIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 584 AUSTRALIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 585 AUSTRALIA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 586 AUSTRALIA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 587 AUSTRALIA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 588 AUSTRALIA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 589 AUSTRALIA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 590 AUSTRALIA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 591 AUSTRALIA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 592 AUSTRALIA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 593 AUSTRALIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 594 AUSTRALIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 595 AUSTRALIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 596 AUSTRALIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 597 AUSTRALIA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 598 AUSTRALIA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 599 AUSTRALIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 600 AUSTRALIA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 601 AUSTRALIA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 602 AUSTRALIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 603 AUSTRALIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 604 AUSTRALIA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 605 AUSTRALIA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 606 AUSTRALIA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 607 AUSTRALIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 608 AUSTRALIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 609 AUSTRALIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 610 AUSTRALIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 611 SOUTH KOREA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 612 SOUTH KOREA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 613 SOUTH KOREA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 614 SOUTH KOREA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 615 SOUTH KOREA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 616 SOUTH KOREA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 617 SOUTH KOREA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 618 SOUTH KOREA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 619 SOUTH KOREA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 620 SOUTH KOREA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 621 SOUTH KOREA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 622 SOUTH KOREA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 623 SOUTH KOREA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 624 SOUTH KOREA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 625 SOUTH KOREA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 626 SOUTH KOREA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 627 SOUTH KOREA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 628 SOUTH KOREA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 629 SOUTH KOREA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 630 SOUTH KOREA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 631 SOUTH KOREA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 632 SOUTH KOREA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 633 SOUTH KOREA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 634 SOUTH KOREA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 635 SOUTH KOREA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 636 SOUTH KOREA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 637 SOUTH KOREA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 638 INDONESIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 639 INDONESIA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 640 INDONESIA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 641 INDONESIA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 642 INDONESIA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 643 INDONESIA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 644 INDONESIA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 645 INDONESIA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 646 INDONESIA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 647 INDONESIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 648 INDONESIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 649 INDONESIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 650 INDONESIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 651 INDONESIA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 652 INDONESIA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 653 INDONESIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 654 INDONESIA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 655 INDONESIA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 656 INDONESIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 657 INDONESIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 658 INDONESIA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 659 INDONESIA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 660 INDONESIA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 661 INDONESIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 662 INDONESIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 663 INDONESIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 664 INDONESIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 665 PHILIPPINES LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 666 PHILIPPINES CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 667 PHILIPPINES GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 668 PHILIPPINES METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 669 PHILIPPINES LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 670 PHILIPPINES URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 671 PHILIPPINES CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 672 PHILIPPINES HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 673 PHILIPPINES COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 674 PHILIPPINES MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 675 PHILIPPINES MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 676 PHILIPPINES MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 677 PHILIPPINES MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 678 PHILIPPINES MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 679 PHILIPPINES OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 680 PHILIPPINES LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 681 PHILIPPINES CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 682 PHILIPPINES ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 683 PHILIPPINES LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 684 PHILIPPINES LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 685 PHILIPPINES INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 686 PHILIPPINES GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 687 PHILIPPINES ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 688 PHILIPPINES LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 689 PHILIPPINES LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 690 PHILIPPINES LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 691 PHILIPPINES LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 692 THAILAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 693 THAILAND CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 694 THAILAND GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 695 THAILAND METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 696 THAILAND LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 697 THAILAND URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 698 THAILAND CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 699 THAILAND HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 700 THAILAND COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 701 THAILAND MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 702 THAILAND MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 703 THAILAND MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 704 THAILAND MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 705 THAILAND MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 706 THAILAND OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 707 THAILAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 708 THAILAND CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 709 THAILAND ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 710 THAILAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 711 THAILAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 712 THAILAND INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 713 THAILAND GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 714 THAILAND ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 715 THAILAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 716 THAILAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 717 THAILAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 718 THAILAND LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 719 MALAYSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 720 MALAYSIA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 721 MALAYSIA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 722 MALAYSIA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 723 MALAYSIA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 724 MALAYSIA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 725 MALAYSIA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 726 MALAYSIA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 727 MALAYSIA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 728 MALAYSIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 729 MALAYSIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 730 MALAYSIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 731 MALAYSIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 732 MALAYSIA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 733 MALAYSIA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 734 MALAYSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 735 MALAYSIA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 736 MALAYSIA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 737 MALAYSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 738 MALAYSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 739 MALAYSIA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 740 MALAYSIA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 741 MALAYSIA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 742 MALAYSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 743 MALAYSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 744 MALAYSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 745 MALAYSIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 746 SINGAPORE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 747 SINGAPORE CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 748 SINGAPORE GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 749 SINGAPORE METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 750 SINGAPORE LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 751 SINGAPORE URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 752 SINGAPORE CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 753 SINGAPORE HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 754 SINGAPORE COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 755 SINGAPORE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 756 SINGAPORE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 757 SINGAPORE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 758 SINGAPORE MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 759 SINGAPORE MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 760 SINGAPORE OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 761 SINGAPORE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 762 SINGAPORE CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 763 SINGAPORE ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 764 SINGAPORE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 765 SINGAPORE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 766 SINGAPORE INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 767 SINGAPORE GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 768 SINGAPORE ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 769 SINGAPORE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 770 SINGAPORE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 771 SINGAPORE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 772 SINGAPORE LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 773 REST OF ASIA PACIFIC LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 774 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 775 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 776 SOUTH AMERICA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 777 SOUTH AMERICA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 778 SOUTH AMERICA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 779 SOUTH AMERICA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 780 SOUTH AMERICA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 781 SOUTH AMERICA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 782 SOUTH AMERICA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 783 SOUTH AMERICA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 784 SOUTH AMERICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 785 SOUTH AMERICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 786 SOUTH AMERICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 787 SOUTH AMERICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 788 SOUTH AMERICA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 789 SOUTH AMERICA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 790 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 791 SOUTH AMERICA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 792 SOUTH AMERICA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 793 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 794 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 795 SOUTH AMERICA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 796 SOUTH AMERICA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 797 SOUTH AMERICA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 798 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 799 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 800 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 801 SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 802 BRAZIL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 803 BRAZIL CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 804 BRAZIL GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 805 BRAZIL METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 806 BRAZIL LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 807 BRAZIL URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 808 BRAZIL CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 809 BRAZIL HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 810 BRAZIL COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 811 BRAZIL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 812 BRAZIL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 813 BRAZIL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 814 BRAZIL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 815 BRAZIL MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 816 BRAZIL OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 817 BRAZIL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 818 BRAZIL CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 819 BRAZIL ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 820 BRAZIL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 821 BRAZIL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 822 BRAZIL INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 823 BRAZIL GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 824 BRAZIL ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 825 BRAZIL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 826 BRAZIL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 827 BRAZIL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 828 BRAZIL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 829 ARGENTINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 830 ARGENTINA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 831 ARGENTINA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 832 ARGENTINA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 833 ARGENTINA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 834 ARGENTINA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 835 ARGENTINA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 836 ARGENTINA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 837 ARGENTINA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 838 ARGENTINA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 839 ARGENTINA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 840 ARGENTINA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 841 ARGENTINA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 842 ARGENTINA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 843 ARGENTINA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 844 ARGENTINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 845 ARGENTINA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 846 ARGENTINA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 847 ARGENTINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 848 ARGENTINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 849 ARGENTINA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 850 ARGENTINA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 851 ARGENTINA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 852 ARGENTINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 853 ARGENTINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 854 ARGENTINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 855 ARGENTINA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 856 REST OF SOUTH AMERICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 857 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 858 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 859 MIDDLE EAST AND AFRICA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 860 MIDDLE EAST AND AFRICA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 861 MIDDLE EAST AND AFRICA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 862 MIDDLE EAST AND AFRICA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 863 MIDDLE EAST AND AFRICA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 864 MIDDLE EAST AND AFRICA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 865 MIDDLE EAST AND AFRICA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 866 MIDDLE EAST AND AFRICA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 867 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 868 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 869 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 870 MIDDLE EAST AND AFRICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 871 MIDDLE EAST AND AFRICA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 872 MIDDLE EAST AND AFRICA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 873 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 874 MIDDLE EAST AND AFRICA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 875 MIDDLE EAST AND AFRICA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 876 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 877 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 878 MIDDLE EAST AND AFRICA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 879 MIDDLE EAST AND AFRICA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 880 MIDDLE EAST AND AFRICA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 881 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 882 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 883 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 884 MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 885 SAUDI ARABIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 886 SAUDI ARABIA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 887 SAUDI ARABIA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 888 SAUDI ARABIA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 889 SAUDI ARABIA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 890 SAUDI ARABIA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 891 SAUDI ARABIA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 892 SAUDI ARABIA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 893 SAUDI ARABIA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 894 SAUDI ARABIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 895 SAUDI ARABIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 896 SAUDI ARABIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 897 SAUDI ARABIA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 898 SAUDI ARABIA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 899 SAUDI ARABIA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 900 SAUDI ARABIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 901 SAUDI ARABIA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 902 SAUDI ARABIA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 903 SAUDI ARABIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 904 SAUDI ARABIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 905 SAUDI ARABIA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 906 SAUDI ARABIA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 907 SAUDI ARABIA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 908 SAUDI ARABIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 909 SAUDI ARABIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 910 SAUDI ARABIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 911 SAUDI ARABIA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 912 SOUTH AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 913 SOUTH AFRICA CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 914 SOUTH AFRICA GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 915 SOUTH AFRICA METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 916 SOUTH AFRICA LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 917 SOUTH AFRICA URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 918 SOUTH AFRICA CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 919 SOUTH AFRICA HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 920 SOUTH AFRICA COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 921 SOUTH AFRICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 922 SOUTH AFRICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 923 SOUTH AFRICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 924 SOUTH AFRICA MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 925 SOUTH AFRICA MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 926 SOUTH AFRICA OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 927 SOUTH AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 928 SOUTH AFRICA CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 929 SOUTH AFRICA ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 930 SOUTH AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 931 SOUTH AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 932 SOUTH AFRICA INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 933 SOUTH AFRICA GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 934 SOUTH AFRICA ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 935 SOUTH AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 936 SOUTH AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 937 SOUTH AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 938 SOUTH AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 939 U.A.E LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 940 U.A.E CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 941 U.A.E GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 942 U.A.E METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 943 U.A.E LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 944 U.A.E URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 945 U.A.E CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 946 U.A.E HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 947 U.A.E COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 948 U.A.E MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 949 U.A.E MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 950 U.A.E MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 951 U.A.E MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 952 U.A.E MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 953 U.A.E OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 954 U.A.E LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 955 U.A.E CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 956 U.A.E ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 957 U.A.E LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 958 U.A.E LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 959 U.A.E INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 960 U.A.E GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 961 U.A.E ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 962 U.A.E LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 963 U.A.E LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 964 U.A.E LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 965 U.A.E LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 966 EGYPT LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 967 EGYPT CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 968 EGYPT GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 969 EGYPT METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 970 EGYPT LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 971 EGYPT URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 972 EGYPT CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 973 EGYPT HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 974 EGYPT COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 975 EGYPT MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 976 EGYPT MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 977 EGYPT MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 978 EGYPT MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 979 EGYPT MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 980 EGYPT OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 981 EGYPT LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 982 EGYPT CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 983 EGYPT ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 984 EGYPT LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 985 EGYPT LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 986 EGYPT INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 987 EGYPT GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 988 EGYPT ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 989 EGYPT LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 990 EGYPT LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 991 EGYPT LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 992 EGYPT LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 993 ISRAEL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 994 ISRAEL CLINICAL CHEMISTRY AND IMMUNOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 995 ISRAEL GLUCOSE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 996 ISRAEL METABOLIC PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 997 ISRAEL LIVER PANEL IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 998 ISRAEL URINALYSIS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 999 ISRAEL CRITICAL CARE IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 1000 ISRAEL HAEMATOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 1001 ISRAEL COMPLETE BLOOD COUNT (CBC) IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 1002 ISRAEL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 1003 ISRAEL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 1004 ISRAEL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TECHNOLOGY, 2021-2030 (USD MILLION)
TABLE 1005 ISRAEL MOLECULAR DIAGNOSTICS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 1006 ISRAEL MICROBIOLOGY IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 1007 ISRAEL OTHER TEST IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)
TABLE 1008 ISRAEL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 1009 ISRAEL CONSUMABLES IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 1010 ISRAEL ANALYZERS AND INSTRUMENTS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 1011 ISRAEL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY SAMPLE TYPE, 2021-2030 (USD MILLION)
TABLE 1012 ISRAEL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 1013 ISRAEL INFECTIONS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 1014 ISRAEL GENETIC DISORDERS IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 1015 ISRAEL ONCOLOGY/CANCER IN LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY THERAPEUTIC AREA, 2021-2030 (USD MILLION)
TABLE 1016 ISRAEL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY GENDER, 2021-2030 (USD MILLION)
TABLE 1017 ISRAEL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY AGE GROUP, 2021-2030 (USD MILLION)
TABLE 1018 ISRAEL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY END USERS, 2021-2030 (USD MILLION)
TABLE 1019 ISRAEL LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 1020 REST OF MIDDLE EAST AND AFRICA LABORATORY-DEVELOPED TESTS (LDTS) MARKET, BY TEST TYPE, 2021-2030 (USD MILLION)